Clinical trial
A Phase II, Open-Label, Multicenter Trial to Investigate the Clinical Activity and Safety of Avelumab (MSB0010718C) in Subjects With Merkel Cell Carcinoma
NCT02155647 is registered in ClinicalTrials.gov with EMD Serono Research & Development Institute, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II, Open-Label, Multicenter Trial to Investigate the Clinical Activity and Safety of Avelumab (MSB0010718C) in Subjects With Merkel Cell Carcinoma
- Lead sponsor
- EMD Serono Research & Development Institute, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 3, 2014
- Completion date
- May 3, 2023
- Enrollment
- 204 (actual)
- Sites
- 61
Conditions
As the registry lists them; a condition with its own page is linked.